Palo Alto Networks Form 4: Klarich 10b5-1 Sales and Option Exercise
Rhea-AI Filing Summary
Lee Klarich, EVP Chief Product & Tech Officer and director at Palo Alto Networks (PANW), reported multiple transactions on Form 4. On 09/03/2025 he exercised 92,010 stock options with an exercise price of $32.25, resulting in the acquisition of 92,010 shares. On the same date he sold a series of shares under a Rule 10b5-1 plan adopted on 09/27/2024: 2,282; 5,544; 50,699; 61,600; and 649 shares at weighted-average prices ranging from about $188.16 up to $192.31 per share. Following these transactions his reported direct beneficial ownership figures include 177,954 shares (direct) and 740,000 shares held indirectly by the Klarich 2005 Trust for which he and his spouse are trustees. The exercised options are fully vested and exercisable.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider exercised vested options and sold a material block under a pre-existing 10b5-1 plan; transactions appear executed under plan terms.
The reporting shows an option exercise of 92,010 shares at a $32.25 exercise price and contemporaneous sales totaling 120,774 shares executed under a Rule 10b5-1 plan adopted 09/27/2024. The sale prices are reported as weighted-average ranges between approximately $188.16 and $192.31 per share. This combination of exercise and sales is commonly used to satisfy tax and liquidity needs while preserving ownership via an indirect trust stake of 740,000 shares. For investors, the activity is notable for size but is disclosed as plan-driven rather than ad hoc trading.
TL;DR: Governance disclosure is clear—sales were under a 10b5-1 plan and indirect holdings are disclosed via a family trust.
The Form 4 identifies the reporting person as both an officer and director and explicitly states that sales were effected pursuant to a Rule 10b5-1 trading plan. The filing discloses indirect ownership through the Klarich 2005 Trust with the reporting person and spouse as trustees, which clarifies potential control and alignment considerations. Signatory and explanatory footnotes provide the weighted-average price ranges and offer to provide per-price breakdowns upon request, supporting transparency.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 92,010 | $0.00 | $0.00 |
| Exercise | Common Stock | 92,010 | $32.25 | $2.97M |
| Sale | Common Stock | 2,282 | $188.604 | $430K |
| Sale | Common Stock | 5,544 | $189.757 | $1.05M |
| Sale | Common Stock | 50,699 | $190.797 | $9.67M |
| Sale | Common Stock | 61,600 | $191.571 | $11.80M |
| Sale | Common Stock | 649 | $192.223 | $125K |
| holding | Common Stock | -- | -- | -- |
Footnotes (8)
- F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 27, 2024.
- F2. This sale price represents the weighted average sale price of the shares sold ranging from $188.155 to $189.035 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3. This sale price represents the weighted average sale price of the shares sold ranging from $189.175 to $190.165 per share. Upon request by the Commission staff, the Issuer, or a security holder of the 1Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F4. This sale price represents the weighted average sale price of the shares sold ranging from $190.175 to $191.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F5. This sale price represents the weighted average sale price of the shares sold ranging from $191.18 to $192.175 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F6. This sale price represents the weighted average sale price of the shares sold ranging from $192.18 to $192.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F7. Shares are held by the Klarich 2005 Trust, for which the Reporting Person and his spouse serve as trustees.
- F8. The shares subject to the option are fully vested and exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.